- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Neuropathic pain
- Meeting Date: November 2021
- Public Summary Document (PSD) November 2021 PBAC Meeting - (PDF 1052KB)
- Public Summary Document (PSD) November 2021 PBAC Meeting - (Word 82KB)
Pregabalin – November 2021
Pregabalin: Tablet 82.5 mg, Tablet 165 mg, Tablet 330 mg; Lyrica CR®
Last updated
18 March 2022